Clinical Trial Update: Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Beltavac with a polymerized extract of house dust mite for house dust mite allergy is ongoing, focusing on efficacy and safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• House Dust Mite Allergy

Drugs mentioned

• Beltavac (polymerized extract of house dust mite)

Snippet

Sponsor: Probelte Pharma S.L.U. | Conditions: House Dust Mite Allergy | Phase 3 | Status: RECRUITING